首页 > 最新文献

Archives of pathology & laboratory medicine最新文献

英文 中文
Virginia Anne LiVolsi, MD. 弗吉尼亚-安妮-李沃尔西,医学博士。
Pub Date : 2024-10-01 DOI: 10.5858/arpa.2024-0201-ED
Kathleen T Montone
{"title":"Virginia Anne LiVolsi, MD.","authors":"Kathleen T Montone","doi":"10.5858/arpa.2024-0201-ED","DOIUrl":"10.5858/arpa.2024-0201-ED","url":null,"abstract":"","PeriodicalId":93883,"journal":{"name":"Archives of pathology & laboratory medicine","volume":" ","pages":"1078-1079"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141461281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transfusion Medicine Rotations for Pathology Residents: Structure, Resources, and Milestones. 病理学住院医师输血医学轮转:结构、资源和里程碑。
Pub Date : 2024-10-01 DOI: 10.5858/arpa.2023-0287-EP
Ian M Harrold

Context.—: Transfusion medicine can be a challenging subject to teach to pathology residents while also ensuring that all the Accreditation Council for Graduate Medical Education's (ACGME's) milestones are met.

Objective.—: To explore how one major academic residency program has structured its transfusion medicine rotation.

Design.—: The residents on the pathology rotation have very defined roles for their day-to-day responsibilities. Many new resources have been developed during the past 3 years to improve the residents' educational experience on their transfusion medicine rotation. A daily patient list is used to direct the residents' educational and service responsibilities. They also have numerous resources to help with independent study and reading during their rotation.

Results.—: The implementation of several new resources has greatly improved the residents' educational experience and has improved the overall evaluation of the rotation by the residents. Many of the ACGME milestones can be met by the structure of this rotation.

Conclusions.—: With the proper structure and resources, transfusion medicine can be effectively taught to all pathology residents while also meeting the ACGME milestones requirements.

背景输血医学是一门极具挑战性的学科,既要教授病理住院医师,又要确保达到毕业后医学教育认证委员会(ACGME)的所有里程碑:探索一个大型住院医师培训项目如何安排输血医学轮转:病理学轮转住院医师的日常职责非常明确。在过去 3 年中开发了许多新资源,以改善住院医师在输血医学轮转中的教育体验。每日病人名单用于指导住院医生的教育和服务职责。他们在轮转期间还可以利用大量资源进行自主学习和阅读:结果:几种新资源的使用大大改善了住院医师的教育体验,并提高了住院医师对轮转的总体评价。通过这种轮转的结构,可以达到 ACGME 的许多里程碑:结论:通过适当的结构和资源,输血医学可以有效地传授给所有病理住院医师,同时还能满足 ACGME 里程碑的要求。
{"title":"Transfusion Medicine Rotations for Pathology Residents: Structure, Resources, and Milestones.","authors":"Ian M Harrold","doi":"10.5858/arpa.2023-0287-EP","DOIUrl":"10.5858/arpa.2023-0287-EP","url":null,"abstract":"<p><strong>Context.—: </strong>Transfusion medicine can be a challenging subject to teach to pathology residents while also ensuring that all the Accreditation Council for Graduate Medical Education's (ACGME's) milestones are met.</p><p><strong>Objective.—: </strong>To explore how one major academic residency program has structured its transfusion medicine rotation.</p><p><strong>Design.—: </strong>The residents on the pathology rotation have very defined roles for their day-to-day responsibilities. Many new resources have been developed during the past 3 years to improve the residents' educational experience on their transfusion medicine rotation. A daily patient list is used to direct the residents' educational and service responsibilities. They also have numerous resources to help with independent study and reading during their rotation.</p><p><strong>Results.—: </strong>The implementation of several new resources has greatly improved the residents' educational experience and has improved the overall evaluation of the rotation by the residents. Many of the ACGME milestones can be met by the structure of this rotation.</p><p><strong>Conclusions.—: </strong>With the proper structure and resources, transfusion medicine can be effectively taught to all pathology residents while also meeting the ACGME milestones requirements.</p>","PeriodicalId":93883,"journal":{"name":"Archives of pathology & laboratory medicine","volume":" ","pages":"1166-1171"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139514360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recommendations for Performance Evaluation of Machine Learning in Pathology: A Concept Paper From the College of American Pathologists. 病理学中机器学习性能评估的建议:来自美国病理学家学院的概念论文。
Pub Date : 2024-10-01 DOI: 10.5858/arpa.2023-0042-CP
Matthew G Hanna, Niels H Olson, Mark Zarella, Rajesh C Dash, Markus D Herrmann, Larissa V Furtado, Michelle N Stram, Patricia M Raciti, Lewis Hassell, Alex Mays, Liron Pantanowitz, Joseph S Sirintrapun, Savitri Krishnamurthy, Anil Parwani, Giovanni Lujan, Andrew Evans, Eric F Glassy, Marilyn M Bui, Rajendra Singh, Rhona J Souers, Monica E de Baca, Jansen N Seheult

Context.—: Machine learning applications in the pathology clinical domain are emerging rapidly. As decision support systems continue to mature, laboratories will increasingly need guidance to evaluate their performance in clinical practice. Currently there are no formal guidelines to assist pathology laboratories in verification and/or validation of such systems. These recommendations are being proposed for the evaluation of machine learning systems in the clinical practice of pathology.

Objective.—: To propose recommendations for performance evaluation of in vitro diagnostic tests on patient samples that incorporate machine learning as part of the preanalytical, analytical, or postanalytical phases of the laboratory workflow. Topics described include considerations for machine learning model evaluation including risk assessment, predeployment requirements, data sourcing and curation, verification and validation, change control management, human-computer interaction, practitioner training, and competency evaluation.

Data sources.—: An expert panel performed a review of the literature, Clinical and Laboratory Standards Institute guidance, and laboratory and government regulatory frameworks.

Conclusions.—: Review of the literature and existing documents enabled the development of proposed recommendations. This white paper pertains to performance evaluation of machine learning systems intended to be implemented for clinical patient testing. Further studies with real-world clinical data are encouraged to support these proposed recommendations. Performance evaluation of machine learning models is critical to verification and/or validation of in vitro diagnostic tests using machine learning intended for clinical practice.

上下文。-:机器学习在病理临床领域的应用正在迅速兴起。随着决策支持系统的不断成熟,实验室将越来越需要指导来评估他们在临床实践中的表现。目前还没有正式的指南来帮助病理实验室验证和/或确认这些系统。这些建议是为了在病理临床实践中评估机器学习系统而提出的。-:提出对患者样本进行体外诊断测试的性能评估建议,将机器学习作为实验室工作流程的分析前、分析或分析后阶段的一部分。所描述的主题包括对机器学习模型评估的考虑,包括风险评估、预部署需求、数据来源和管理、验证和确认、变更控制管理、人机交互、从业者培训和能力评估。数据源。-:一个专家小组对文献、临床和实验室标准协会指南、实验室和政府监管框架进行了审查。-:对文献和现有文件的审查使提出建议成为可能。本白皮书涉及用于临床患者测试的机器学习系统的性能评估。鼓励对真实世界的临床数据进行进一步的研究来支持这些建议。机器学习模型的性能评估对于使用机器学习进行临床实践的体外诊断测试的验证和/或验证至关重要。
{"title":"Recommendations for Performance Evaluation of Machine Learning in Pathology: A Concept Paper From the College of American Pathologists.","authors":"Matthew G Hanna, Niels H Olson, Mark Zarella, Rajesh C Dash, Markus D Herrmann, Larissa V Furtado, Michelle N Stram, Patricia M Raciti, Lewis Hassell, Alex Mays, Liron Pantanowitz, Joseph S Sirintrapun, Savitri Krishnamurthy, Anil Parwani, Giovanni Lujan, Andrew Evans, Eric F Glassy, Marilyn M Bui, Rajendra Singh, Rhona J Souers, Monica E de Baca, Jansen N Seheult","doi":"10.5858/arpa.2023-0042-CP","DOIUrl":"10.5858/arpa.2023-0042-CP","url":null,"abstract":"<p><strong>Context.—: </strong>Machine learning applications in the pathology clinical domain are emerging rapidly. As decision support systems continue to mature, laboratories will increasingly need guidance to evaluate their performance in clinical practice. Currently there are no formal guidelines to assist pathology laboratories in verification and/or validation of such systems. These recommendations are being proposed for the evaluation of machine learning systems in the clinical practice of pathology.</p><p><strong>Objective.—: </strong>To propose recommendations for performance evaluation of in vitro diagnostic tests on patient samples that incorporate machine learning as part of the preanalytical, analytical, or postanalytical phases of the laboratory workflow. Topics described include considerations for machine learning model evaluation including risk assessment, predeployment requirements, data sourcing and curation, verification and validation, change control management, human-computer interaction, practitioner training, and competency evaluation.</p><p><strong>Data sources.—: </strong>An expert panel performed a review of the literature, Clinical and Laboratory Standards Institute guidance, and laboratory and government regulatory frameworks.</p><p><strong>Conclusions.—: </strong>Review of the literature and existing documents enabled the development of proposed recommendations. This white paper pertains to performance evaluation of machine learning systems intended to be implemented for clinical patient testing. Further studies with real-world clinical data are encouraged to support these proposed recommendations. Performance evaluation of machine learning models is critical to verification and/or validation of in vitro diagnostic tests using machine learning intended for clinical practice.</p>","PeriodicalId":93883,"journal":{"name":"Archives of pathology & laboratory medicine","volume":" ","pages":"e335-e361"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138471378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification of Glandular (Acinar)/Tubule Formation in Invasive Carcinoma of the Breast: A Study to Determine Concordance Using the World Health Organization Definition. 乳腺浸润性癌中腺体(腺泡)/小管形成的鉴定:使用世界卫生组织定义确定一致性的研究。
Pub Date : 2024-10-01 DOI: 10.5858/arpa.2023-0163-OA
Yungtai Lo, Susan C Lester, Ian O Ellis, Sonali Lanjewar, Javier Laurini, Ami Patel, Ava Bhattarai, Berrin Ustun, Bryan Harmon, Celina G Kleer, Dara Ross, Ali Amin, Yihong Wang, Robert Bradley, Gulisa Turashvili, Jennifer Zeng, Jordan Baum, Kamaljeet Singh, Laleh Hakima, Malini Harigopal, Miglena Komforti, Sandra J Shin, Sara E Abbott, Shabnam Jaffer, Sunil Shankar Badve, Thaer Khoury, Timothy M D'Alfonso, Paula S Ginter, Victoria Collins, William Towne, Yujun Gan, Aziza Nassar, Aysegul A Sahin, Andrea Flieder, Rana Aldrees, Marie-Helene Ngo, Ukuemi Edema, Fnu Sapna, Stuart J Schnitt, Susan A Fineberg

Context.—: The Nottingham Grading System (NGS) developed by Elston and Ellis is used to grade invasive breast cancer (IBC). Glandular (acinar)/tubule formation is a component of NGS.

Objective.—: To investigate the ability of pathologists to identify individual structures that should be classified as glandular (acinar)/tubule formation.

Design.—: A total of 58 hematoxylin-eosin photographic images of IBC with 1 structure circled were classified as tubules (41 cases) or nontubules (17 cases) by Professor Ellis. Images were sent as a PowerPoint (Microsoft) file to breast pathologists, who were provided with the World Health Organization definition of a tubule and asked to determine if a circled structure represented a tubule.

Results.—: Among 35 pathologists, the κ statistic for assessing agreement in evaluating the 58 images was 0.324 (95% CI, 0.314-0.335). The median concordance rate between a participating pathologist and Professor Ellis was 94.1% for evaluating 17 nontubule cases and 53.7% for 41 tubule cases. A total of 41% of the tubule cases were classified correctly by less than 50% of pathologists. Structures classified as tubules by Professor Ellis but often not recognized as tubules by pathologists included glands with complex architecture, mucinous carcinoma, and the "inverted tubule" pattern of micropapillary carcinoma. A total of 80% of participants reported that they did not have clarity on what represented a tubule.

Conclusions.—: We identified structures that should be included as tubules but that were not readily identified by pathologists. Greater concordance for identification of tubules might be obtained by providing more detailed images and descriptions of the types of structures included as tubules.

背景:Elston 和 Ellis 开发的诺丁汉分级系统 (NGS) 用于对浸润性乳腺癌 (IBC) 进行分级。腺体(针叶)/微管形成是 NGS 的一个组成部分:研究病理学家识别应归类为腺体(针叶)/微管形成的单个结构的能力:Ellis教授将58张IBC的苏木精-伊红摄影图像中圈定的1个结构分类为小管(41例)或非小管(17例)。图像以 PowerPoint(微软)文件的形式发送给乳腺病理学家,并向他们提供世界卫生组织对小管的定义,要求他们判断圈出的结构是否代表小管:在 35 位病理学家中,评估 58 幅图像一致性的 κ 统计量为 0.324(95% CI,0.314-0.335)。参与研究的病理学家与 Ellis 教授在评估 17 个非小管病例时的一致率中位数为 94.1%,在评估 41 个小管病例时的一致率中位数为 53.7%。共有 41% 的小管病例被少于 50% 的病理学家正确分类。被埃利斯教授归类为小管但病理学家通常不认为是小管的结构包括结构复杂的腺体、粘液癌以及微乳头状癌的 "倒置小管 "模式。共有 80% 的参与者表示,他们并不清楚什么是小管:我们发现了一些应被列为小管的结构,但病理学家并不容易识别。通过提供更详细的图像和对小管结构类型的描述,可能会提高小管识别的一致性。
{"title":"Identification of Glandular (Acinar)/Tubule Formation in Invasive Carcinoma of the Breast: A Study to Determine Concordance Using the World Health Organization Definition.","authors":"Yungtai Lo, Susan C Lester, Ian O Ellis, Sonali Lanjewar, Javier Laurini, Ami Patel, Ava Bhattarai, Berrin Ustun, Bryan Harmon, Celina G Kleer, Dara Ross, Ali Amin, Yihong Wang, Robert Bradley, Gulisa Turashvili, Jennifer Zeng, Jordan Baum, Kamaljeet Singh, Laleh Hakima, Malini Harigopal, Miglena Komforti, Sandra J Shin, Sara E Abbott, Shabnam Jaffer, Sunil Shankar Badve, Thaer Khoury, Timothy M D'Alfonso, Paula S Ginter, Victoria Collins, William Towne, Yujun Gan, Aziza Nassar, Aysegul A Sahin, Andrea Flieder, Rana Aldrees, Marie-Helene Ngo, Ukuemi Edema, Fnu Sapna, Stuart J Schnitt, Susan A Fineberg","doi":"10.5858/arpa.2023-0163-OA","DOIUrl":"10.5858/arpa.2023-0163-OA","url":null,"abstract":"<p><strong>Context.—: </strong>The Nottingham Grading System (NGS) developed by Elston and Ellis is used to grade invasive breast cancer (IBC). Glandular (acinar)/tubule formation is a component of NGS.</p><p><strong>Objective.—: </strong>To investigate the ability of pathologists to identify individual structures that should be classified as glandular (acinar)/tubule formation.</p><p><strong>Design.—: </strong>A total of 58 hematoxylin-eosin photographic images of IBC with 1 structure circled were classified as tubules (41 cases) or nontubules (17 cases) by Professor Ellis. Images were sent as a PowerPoint (Microsoft) file to breast pathologists, who were provided with the World Health Organization definition of a tubule and asked to determine if a circled structure represented a tubule.</p><p><strong>Results.—: </strong>Among 35 pathologists, the κ statistic for assessing agreement in evaluating the 58 images was 0.324 (95% CI, 0.314-0.335). The median concordance rate between a participating pathologist and Professor Ellis was 94.1% for evaluating 17 nontubule cases and 53.7% for 41 tubule cases. A total of 41% of the tubule cases were classified correctly by less than 50% of pathologists. Structures classified as tubules by Professor Ellis but often not recognized as tubules by pathologists included glands with complex architecture, mucinous carcinoma, and the \"inverted tubule\" pattern of micropapillary carcinoma. A total of 80% of participants reported that they did not have clarity on what represented a tubule.</p><p><strong>Conclusions.—: </strong>We identified structures that should be included as tubules but that were not readily identified by pathologists. Greater concordance for identification of tubules might be obtained by providing more detailed images and descriptions of the types of structures included as tubules.</p>","PeriodicalId":93883,"journal":{"name":"Archives of pathology & laboratory medicine","volume":" ","pages":"1119-1125"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139514351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is Social Media Here to Stay?: Survey Results Indicate Increasing Pathologist Interest and Engagement Over Time. 社交媒体会继续存在吗?调查结果显示病理学家对社交媒体的兴趣和参与度与日俱增。
Pub Date : 2024-10-01 DOI: 10.5858/arpa.2023-0387-OA
Raul S Gonzalez, Elizabeth L McKinnon, Maren Y Fuller, Jerad M Gardner, Wei Chen, Xiaoyin Sara Jiang

Context.—: Social media has become widely adopted by pathologists and other physicians for professional purposes. While engagement has likely increased over time, there remain few concrete data regarding attitudes toward its use.

Objective.—: To assess pathologists' use of and attitudes toward social media over time.

Design.—: We created a survey regarding personal and professional use of social media and circulated it via multiple channels in December 2017 and again in February 2022. Results of the 2 surveys were compared for statistically significant differences.

Results.—: The 2017 survey was completed by 97 participants, and the 2022 survey by 305 participants. Respondents were predominantly female and academics, included pathologists in all age categories and all time-in-practice length. In both surveys, Twitter (now X) was the most popular platform for professional use and Facebook was the most popular for personal use. Professional barriers to social media use remained consistent between the 2 surveys, including the amount of time required. Education was seen as the main benefit of social media use in both surveys, while other benefits such as networking and increasing professional visibility were endorsed significantly less often in the second survey. While the second survey received more than 3 times as many responses as the first, several aspects of social media use (mainly demographics) remained similar during the timeframe, while other aspects (such as usage and perceived values) decreased.

Conclusions.—: Pathologists continue to find social media valuable. Barriers remain, though overall pathologists of all ages and practice settings appear receptive to using social media to further educational and other opportunities.

背景病理学家和其他医生出于专业目的广泛使用社交媒体。虽然随着时间的推移,参与度可能会有所提高,但有关其使用态度的具体数据仍然很少:评估病理学家随着时间推移对社交媒体的使用情况和态度:我们制作了一份关于社交媒体的个人和专业使用情况的调查表,并于 2017 年 12 月和 2022 年 2 月通过多种渠道分发。我们对两次调查的结果进行了比较,以发现统计学上的显著差异:有 97 人完成了 2017 年的调查,305 人完成了 2022 年的调查。受访者以女性和学者为主,包括所有年龄段和执业时间长短的病理学家。在两次调查中,Twitter(现为 X)是最受欢迎的专业使用平台,而 Facebook 则是最受欢迎的个人使用平台。在两次调查中,使用社交媒体的专业障碍保持一致,包括所需的时间。在两次调查中,教育都被视为使用社交媒体的主要益处,而在第二次调查中,网络和提高专业知名度等其他益处被认可的次数明显较少。虽然第二次调查收到的回复是第一次调查的三倍多,但在这段时间内,社交媒体使用的几个方面(主要是人口统计学)保持相似,而其他方面(如使用率和认知价值)则有所下降:病理学家仍然认为社交媒体很有价值。病理学家仍然认为社交媒体很有价值,但障碍依然存在,不过总体而言,所有年龄段和执业环境的病理学家似乎都乐于使用社交媒体来促进教育和其他机会。
{"title":"Is Social Media Here to Stay?: Survey Results Indicate Increasing Pathologist Interest and Engagement Over Time.","authors":"Raul S Gonzalez, Elizabeth L McKinnon, Maren Y Fuller, Jerad M Gardner, Wei Chen, Xiaoyin Sara Jiang","doi":"10.5858/arpa.2023-0387-OA","DOIUrl":"10.5858/arpa.2023-0387-OA","url":null,"abstract":"<p><strong>Context.—: </strong>Social media has become widely adopted by pathologists and other physicians for professional purposes. While engagement has likely increased over time, there remain few concrete data regarding attitudes toward its use.</p><p><strong>Objective.—: </strong>To assess pathologists' use of and attitudes toward social media over time.</p><p><strong>Design.—: </strong>We created a survey regarding personal and professional use of social media and circulated it via multiple channels in December 2017 and again in February 2022. Results of the 2 surveys were compared for statistically significant differences.</p><p><strong>Results.—: </strong>The 2017 survey was completed by 97 participants, and the 2022 survey by 305 participants. Respondents were predominantly female and academics, included pathologists in all age categories and all time-in-practice length. In both surveys, Twitter (now X) was the most popular platform for professional use and Facebook was the most popular for personal use. Professional barriers to social media use remained consistent between the 2 surveys, including the amount of time required. Education was seen as the main benefit of social media use in both surveys, while other benefits such as networking and increasing professional visibility were endorsed significantly less often in the second survey. While the second survey received more than 3 times as many responses as the first, several aspects of social media use (mainly demographics) remained similar during the timeframe, while other aspects (such as usage and perceived values) decreased.</p><p><strong>Conclusions.—: </strong>Pathologists continue to find social media valuable. Barriers remain, though overall pathologists of all ages and practice settings appear receptive to using social media to further educational and other opportunities.</p>","PeriodicalId":93883,"journal":{"name":"Archives of pathology & laboratory medicine","volume":" ","pages":"1159-1165"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139731150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Detection of Carbapenem Resistance in Enterobacterales Directly From Positive Blood Cultures Using Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry. 利用基质辅助激光解吸电离飞行时间质谱法直接从阳性血液培养物中检测肠杆菌对碳青霉烯类的耐药性
Pub Date : 2024-10-01 DOI: 10.5858/arpa.2023-0199-OA
Natália Kehl Moreira, Camila Mörschbächer Wilhelm, Fabiana Caroline Zempulski Volpato, Afonso Luís Barth, Juliana Caierão

Context.—: Carbapenem-resistant Enterobacterales are disseminated worldwide and associated with infections with high rates of morbidity and mortality. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) is a useful tool for identification of pathogens directly from blood cultures in clinical microbiology laboratories. Furthermore, it has been applied for the detection of carbapenemase production, by evaluating carbapenem hydrolysis.

Objective.—: To determine meropenem hydrolysis to detect carbapenemase production directly from positive blood cultures, using logRQ to establish a quantitative measure of hydrolysis.

Design.—: We evaluated 100 Enterobacterales from positive blood cultures, with 81 carrying a carbapenemase gene (blaKPC, blaGES, blaNDM-1, blaIMP, blaVIM, and blaOXA-48-like), as determined by real-time multiplex polymerase chain reaction with high-resolution melting (HRM-qPCR). Bacterial proteins extracted from positive blood culture bottles were incubated in a meropenem solution (2-4 hours) followed by centrifugation for MALDI-TOF MS analysis. The intensity of peaks of the hydrolyzed and nonhydrolyzed forms were used to calculate the logRQ value.

Results.—: Overall, sensitivity was 86.8% and specificity, 89.5%. Of note, sensitivity varied depending on enzyme type. For blaKPC-positive isolates, sensitivity was 97.9%, while it reduced significantly for blaNDM-1 and blaOXA-48-like isolates: 62.5% (10 of 16) and 66.7% (6 of 9), respectively. Indeed, logRQ was higher in blaKPC-positive isolates (0.37-1.97) than in blaNDM-1 (-1.37 to 0.83) and blaOXA-48-like isolates (-1.08 to 1.79).

Conclusions.—: This is an inexpensive and rapid test to identify carbapenemase activity directly from blood culture bottles, which contributes to early adequate antimicrobial therapy and implementation of infection control measures.

背景耐碳青霉烯类肠杆菌在全球范围内传播,与发病率和死亡率较高的感染有关。基质辅助激光解吸电离飞行时间质谱(MALDI-TOF MS)是临床微生物实验室直接从血液培养物中鉴定病原体的有效工具。此外,它还被用于通过评估碳青霉烯水解作用来检测碳青霉烯酶的产生:确定美罗培南的水解度,直接从阳性血液培养物中检测碳青霉烯酶的产生,使用 logRQ 确定水解度的定量指标:我们评估了阳性血液培养物中的 100 种肠杆菌,其中 81 种携带碳青霉烯酶基因(blaKPC、blaGES、blaNDM-1、blaIMP、blaVIM 和 blaOXA-48-like),并通过实时多聚酶链反应和高分辨率熔解(HRM-qPCR)进行了测定。从阳性血培养瓶中提取的细菌蛋白质在美罗培南溶液中培养(2-4 小时)后离心,进行 MALDI-TOF MS 分析。水解和非水解形式的峰强度用于计算 logRQ 值:总体而言,灵敏度为 86.8%,特异性为 89.5%。值得注意的是,灵敏度因酶的类型而异。对于 blaKPC 阳性的分离物,灵敏度为 97.9%,而对于 blaNDM-1 和 blaOXA-48 样分离物,灵敏度明显降低:分别为 62.5%(16 个中的 10 个)和 66.7%(9 个中的 6 个)。事实上,blaKPC 阳性分离物的 logRQ(0.37-1.97)高于 blaNDM-1(-1.37 至 0.83)和 blaOXA-48 样分离物(-1.08 至 1.79):结论:这是一种直接从血培养瓶中鉴定碳青霉烯酶活性的廉价而快速的检测方法,有助于及早进行适当的抗菌治疗和实施感染控制措施。
{"title":"Detection of Carbapenem Resistance in Enterobacterales Directly From Positive Blood Cultures Using Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry.","authors":"Natália Kehl Moreira, Camila Mörschbächer Wilhelm, Fabiana Caroline Zempulski Volpato, Afonso Luís Barth, Juliana Caierão","doi":"10.5858/arpa.2023-0199-OA","DOIUrl":"10.5858/arpa.2023-0199-OA","url":null,"abstract":"<p><strong>Context.—: </strong>Carbapenem-resistant Enterobacterales are disseminated worldwide and associated with infections with high rates of morbidity and mortality. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) is a useful tool for identification of pathogens directly from blood cultures in clinical microbiology laboratories. Furthermore, it has been applied for the detection of carbapenemase production, by evaluating carbapenem hydrolysis.</p><p><strong>Objective.—: </strong>To determine meropenem hydrolysis to detect carbapenemase production directly from positive blood cultures, using logRQ to establish a quantitative measure of hydrolysis.</p><p><strong>Design.—: </strong>We evaluated 100 Enterobacterales from positive blood cultures, with 81 carrying a carbapenemase gene (blaKPC, blaGES, blaNDM-1, blaIMP, blaVIM, and blaOXA-48-like), as determined by real-time multiplex polymerase chain reaction with high-resolution melting (HRM-qPCR). Bacterial proteins extracted from positive blood culture bottles were incubated in a meropenem solution (2-4 hours) followed by centrifugation for MALDI-TOF MS analysis. The intensity of peaks of the hydrolyzed and nonhydrolyzed forms were used to calculate the logRQ value.</p><p><strong>Results.—: </strong>Overall, sensitivity was 86.8% and specificity, 89.5%. Of note, sensitivity varied depending on enzyme type. For blaKPC-positive isolates, sensitivity was 97.9%, while it reduced significantly for blaNDM-1 and blaOXA-48-like isolates: 62.5% (10 of 16) and 66.7% (6 of 9), respectively. Indeed, logRQ was higher in blaKPC-positive isolates (0.37-1.97) than in blaNDM-1 (-1.37 to 0.83) and blaOXA-48-like isolates (-1.08 to 1.79).</p><p><strong>Conclusions.—: </strong>This is an inexpensive and rapid test to identify carbapenemase activity directly from blood culture bottles, which contributes to early adequate antimicrobial therapy and implementation of infection control measures.</p>","PeriodicalId":93883,"journal":{"name":"Archives of pathology & laboratory medicine","volume":" ","pages":"1145-1151"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139405567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Surgical Pathologist's (Potential) Role in Placental Microplastic Detection. 外科病理学家在胎盘微塑料检测中(潜在)的作用。
Pub Date : 2024-10-01 DOI: 10.5858/arpa.2024-0172-ED
Casey P Schukow, Jacqueline K Macknis
{"title":"The Surgical Pathologist's (Potential) Role in Placental Microplastic Detection.","authors":"Casey P Schukow, Jacqueline K Macknis","doi":"10.5858/arpa.2024-0172-ED","DOIUrl":"10.5858/arpa.2024-0172-ED","url":null,"abstract":"","PeriodicalId":93883,"journal":{"name":"Archives of pathology & laboratory medicine","volume":" ","pages":"1080-1081"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141617781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Eosinophilic Solid and Cystic Renal Cell Carcinoma: Morphologic and Immunohistochemical Study of 18 Cases and Review of the Literature. 嗜酸性实性和囊性肾细胞癌:18 例病例的形态学和免疫组化研究及文献综述》(Eosinophilic Solid and Cystic Renal Cell Carcinoma: Morphologic and Immunohistochemical Study of 18 Cases and Review of the Literature.
Pub Date : 2024-10-01 DOI: 10.5858/arpa.2023-0122-OA
Qianru Guo, Xin Yao, Bo Yang, Lisha Qi, Frank Wang, Yuhong Guo, Yanxue Liu, Zi Cao, Yalei Wang, Jinpeng Wang, Lingmei Li, Qiujuan Huang, Changxu Liu, Tongyuan Qu, Wei Zhao, Danyang Ren, Manlin Yang, Chenhui Yan, Bin Meng, Cheng Wang, Wenfeng Cao

Context.—: Eosinophilic solid and cystic renal cell carcinoma is now defined in the 5th edition of the 2022 World Health Organization classification of urogenital tumors.

Objective.—: To perform morphologic, immunohistochemical, and preliminary genetic studies about this new entity in China for the purpose of understanding it better.

Design.—: The study includes 18 patients from a regional tertiary oncology center in northern China (Tianjin, China). We investigated the clinical and immunohistochemical features of these cases.

Results.—: The mean age of patients was 49.6 years, and the male to female ratio was 11:7. Macroscopically, 1 case had the classic cystic and solid appearance, whereas the others appeared purely solid. Microscopically, all 18 tumors shared a similar solid and focal macrocystic or microcystic growth pattern, and the cells were characterized by voluminous and eosinophilic cytoplasm, along with coarse amphophilic stippling. Immunohistochemically, most of the tumors had a predominant cytokeratin (CK) 20-positive feature, ranging from focal cytoplasmic staining to diffuse membranous accentuation. Initially, we separated these cases into different immunohistochemical phenotypes. Group 1 (7 of 18; 38.5%) was characterized by positive phospho-4EBP1 and phospho-S6, which can imply hyperactive mechanistic target of rapamycin complex 1 (mTORC1) signaling. Group 2 (4 of 18; 23%) was negative for NF2, probably implying a germline mutation of NF2. Group 3 (7 of 18; 38.5%) consisted of the remaining cases. One case had metastatic spread and exhibited an aggressive clinical course, and we detected cyclin-dependent kinase inhibitor 2A (CDKN2A) mutation in this case; other patients were alive and without disease progression.

Conclusions.—: Our research proposes that eosinophilic solid and cystic renal cell carcinoma exhibits prototypical pathologic features with CK20 positivity and has aggressive potential.

背景嗜酸性实性和囊性肾细胞癌是目前世界卫生组织2022年第5版泌尿生殖系统肿瘤分类中的定义:在中国对这一新实体进行形态学、免疫组化和初步遗传学研究,以便更好地了解它:本研究包括来自中国北方(中国天津)一家地区性三级肿瘤中心的 18 名患者。我们研究了这些病例的临床和免疫组化特征:患者平均年龄为 49.6 岁,男女比例为 11:7。从宏观上看,1 例患者具有典型的囊实性外观,而其他患者则表现为纯实性。显微镜下,所有 18 例肿瘤都有类似的实性和局灶性大囊性或小囊性生长模式,细胞的特点是胞浆多且嗜酸性,伴有粗糙的嗜两性条纹。从免疫组化角度看,大多数肿瘤都以细胞角蛋白(CK)20阳性为主要特征,从局灶性细胞质染色到弥漫性膜状强化不等。最初,我们将这些病例分为不同的免疫组化表型。第 1 组(18 例中有 7 例,占 38.5%)的特征是磷酸化-4EBP1 和磷酸化-S6 阳性,这可能意味着雷帕霉素复合体 1(mTORC1)信号传导亢进。第 2 组(18 例中有 4 例,占 23%)NF2 阴性,可能意味着 NF2 基因突变。第 3 组(18 例中有 7 例,占 38.5%)由其余病例组成。其中一例患者出现转移扩散,临床表现凶险,我们在该例患者中检测到细胞周期蛋白依赖性激酶抑制剂 2A(CDKN2A)突变;其他患者均存活且无疾病进展:我们的研究表明,嗜酸性实性和囊性肾细胞癌具有CK20阳性的典型病理特征,并具有侵袭性。
{"title":"Eosinophilic Solid and Cystic Renal Cell Carcinoma: Morphologic and Immunohistochemical Study of 18 Cases and Review of the Literature.","authors":"Qianru Guo, Xin Yao, Bo Yang, Lisha Qi, Frank Wang, Yuhong Guo, Yanxue Liu, Zi Cao, Yalei Wang, Jinpeng Wang, Lingmei Li, Qiujuan Huang, Changxu Liu, Tongyuan Qu, Wei Zhao, Danyang Ren, Manlin Yang, Chenhui Yan, Bin Meng, Cheng Wang, Wenfeng Cao","doi":"10.5858/arpa.2023-0122-OA","DOIUrl":"10.5858/arpa.2023-0122-OA","url":null,"abstract":"<p><strong>Context.—: </strong>Eosinophilic solid and cystic renal cell carcinoma is now defined in the 5th edition of the 2022 World Health Organization classification of urogenital tumors.</p><p><strong>Objective.—: </strong>To perform morphologic, immunohistochemical, and preliminary genetic studies about this new entity in China for the purpose of understanding it better.</p><p><strong>Design.—: </strong>The study includes 18 patients from a regional tertiary oncology center in northern China (Tianjin, China). We investigated the clinical and immunohistochemical features of these cases.</p><p><strong>Results.—: </strong>The mean age of patients was 49.6 years, and the male to female ratio was 11:7. Macroscopically, 1 case had the classic cystic and solid appearance, whereas the others appeared purely solid. Microscopically, all 18 tumors shared a similar solid and focal macrocystic or microcystic growth pattern, and the cells were characterized by voluminous and eosinophilic cytoplasm, along with coarse amphophilic stippling. Immunohistochemically, most of the tumors had a predominant cytokeratin (CK) 20-positive feature, ranging from focal cytoplasmic staining to diffuse membranous accentuation. Initially, we separated these cases into different immunohistochemical phenotypes. Group 1 (7 of 18; 38.5%) was characterized by positive phospho-4EBP1 and phospho-S6, which can imply hyperactive mechanistic target of rapamycin complex 1 (mTORC1) signaling. Group 2 (4 of 18; 23%) was negative for NF2, probably implying a germline mutation of NF2. Group 3 (7 of 18; 38.5%) consisted of the remaining cases. One case had metastatic spread and exhibited an aggressive clinical course, and we detected cyclin-dependent kinase inhibitor 2A (CDKN2A) mutation in this case; other patients were alive and without disease progression.</p><p><strong>Conclusions.—: </strong>Our research proposes that eosinophilic solid and cystic renal cell carcinoma exhibits prototypical pathologic features with CK20 positivity and has aggressive potential.</p>","PeriodicalId":93883,"journal":{"name":"Archives of pathology & laboratory medicine","volume":" ","pages":"1126-1134"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139572358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metastatic Pleomorphic Lobular Carcinoma of the Breast to the Urinary Bladder: A Report of 10 Cases and Assessment of TRPS1 in the Differential Diagnosis With Plasmacytoid Urothelial Carcinoma. 乳腺多形性分叶状癌转移至膀胱:10例报告及TRPS1与浆液性尿路上皮癌的鉴别诊断评估。
Pub Date : 2024-10-01 DOI: 10.5858/arpa.2023-0379-OA
Guan-Nan Zhang, Barbara Susnik, Emma J Paulsen, Lisa L Lyons, Katiana S Delma, Merce Jorda, Jonathan I Epstein, Oleksandr N Kryvenko

Context.—: Metastatic pleomorphic lobular carcinoma (MPLC) to the bladder is rare and has considerable histologic and immunohistochemical overlap with plasmacytoid urothelial carcinoma (PUC).

Objective.—: To distinguish MPLC from PUC morphologically and immunohistochemically, including a newer marker, TRPS1.

Design.—: Ten MPLCs to the bladder were reassessed and stained with estrogen, progesterone, and androgen receptors; GATA3; keratin 5/6; HMWK; GCDFP-15; and TRPS1. Sixteen PUCs constituted controls.

Results.—: We studied 4 transurethral resections of bladder tumors and 6 biopsies from 10 women (median age, 69 years) who had breast cancer on average 15 years prior. Microscopic patterns included single cells and cords of cells (n = 4), nests/sheets of dyscohesive cells (n = 2), or both (n = 4). All tumors had cells with voluminous eosinophilic cytoplasm and eccentric nuclei mimicking PUC, and 7 of 10 tumors had signet ring cells. MPLCs were positive for estrogen (8 of 10), progesterone (3 of 7), and androgen (4 of 10) receptors; GCDFP-15 (7 of 10); GATA3 (9 of 10); HMWK (7 of 8); and TRPS1 (7 of 10). No MPLCs stained for keratin 5/6 (n = 9). Of 16 PUCs, 2 showed faint and 2 demonstrated strong TRSP1 staining; 7 of 16 were negative for p63.

Conclusions.—: MPLC to bladder often presents in patients with a remote history of breast cancer, exhibiting significant histologic and immunohistochemical overlap with PUC. Based on prior works and the current study, estrogen receptor (particularly SP-1), mammaglobin, and p63 help differentiate MPLC from PUC. Keratin 5/6 may aid in distinguishing a less frequent basal-type PUC because it is typically negative in MPLC. Some PUCs express TRPS1. Caution should be exercised because immunophenotypes of these tumors greatly overlap, and ramifications of misclassification are major.

背景膀胱转移性多形性小叶癌(MPLC)非常罕见,其组织学和免疫组化与浆细胞性尿路上皮癌(PUC)有相当大的重叠:目的:从形态学和免疫组化方面区分膀胱浆细胞性尿路上皮癌(MPLC)和浆细胞性尿路上皮癌(PUC),包括一种新的标记物TRPS1:对 10 例膀胱 MPLC 进行重新评估,并用雌激素、孕激素和雄激素受体、GATA3、角蛋白 5/6、HMWK、GCDFP-15 和 TRPS1 进行染色。16 例 PUC 构成对照组:我们研究了 4 例经尿道切除的膀胱肿瘤和 6 例活检组织,这些组织来自平均 15 年前患过乳腺癌的 10 名妇女(中位年龄 69 岁)。显微镜下的肿瘤形态包括单细胞和细胞束(4 例)、巢状/片状粘连细胞(2 例)或两者兼有(4 例)。所有肿瘤的细胞都有大量嗜酸性细胞质和模仿 PUC 的偏心核,10 个肿瘤中有 7 个有印戒细胞。MPLC的雌激素受体(10个中有8个)、孕激素受体(7个中有3个)和雄激素受体(10个中有4个);GCDFP-15(10个中有7个);GATA3(10个中有9个);HMWK(8个中有7个);TRPS1(10个中有7个)均呈阳性。没有 MPLCs 染色角蛋白 5/6(n = 9)。在 16 个 PUC 中,2 个显示出微弱的 TRSP1 染色,2 个显示出强烈的 TRSP1 染色;16 个 PUC 中,7 个 p63 阴性:结论:膀胱MPLC常出现在有远期乳腺癌病史的患者中,在组织学和免疫组化方面与PUC有明显的重叠。根据之前的研究和本次研究,雌激素受体(尤其是 SP-1)、乳腺球蛋白和 p63 有助于区分 MPLC 和 PUC。角蛋白 5/6 可能有助于区分较少见的基底型 PUC,因为它在 MPLC 中通常呈阴性。有些 PUC 表达 TRPS1。由于这些肿瘤的免疫表型有很大的重叠,因此应谨慎从事,否则会造成严重的分类错误。
{"title":"Metastatic Pleomorphic Lobular Carcinoma of the Breast to the Urinary Bladder: A Report of 10 Cases and Assessment of TRPS1 in the Differential Diagnosis With Plasmacytoid Urothelial Carcinoma.","authors":"Guan-Nan Zhang, Barbara Susnik, Emma J Paulsen, Lisa L Lyons, Katiana S Delma, Merce Jorda, Jonathan I Epstein, Oleksandr N Kryvenko","doi":"10.5858/arpa.2023-0379-OA","DOIUrl":"10.5858/arpa.2023-0379-OA","url":null,"abstract":"<p><strong>Context.—: </strong>Metastatic pleomorphic lobular carcinoma (MPLC) to the bladder is rare and has considerable histologic and immunohistochemical overlap with plasmacytoid urothelial carcinoma (PUC).</p><p><strong>Objective.—: </strong>To distinguish MPLC from PUC morphologically and immunohistochemically, including a newer marker, TRPS1.</p><p><strong>Design.—: </strong>Ten MPLCs to the bladder were reassessed and stained with estrogen, progesterone, and androgen receptors; GATA3; keratin 5/6; HMWK; GCDFP-15; and TRPS1. Sixteen PUCs constituted controls.</p><p><strong>Results.—: </strong>We studied 4 transurethral resections of bladder tumors and 6 biopsies from 10 women (median age, 69 years) who had breast cancer on average 15 years prior. Microscopic patterns included single cells and cords of cells (n = 4), nests/sheets of dyscohesive cells (n = 2), or both (n = 4). All tumors had cells with voluminous eosinophilic cytoplasm and eccentric nuclei mimicking PUC, and 7 of 10 tumors had signet ring cells. MPLCs were positive for estrogen (8 of 10), progesterone (3 of 7), and androgen (4 of 10) receptors; GCDFP-15 (7 of 10); GATA3 (9 of 10); HMWK (7 of 8); and TRPS1 (7 of 10). No MPLCs stained for keratin 5/6 (n = 9). Of 16 PUCs, 2 showed faint and 2 demonstrated strong TRSP1 staining; 7 of 16 were negative for p63.</p><p><strong>Conclusions.—: </strong>MPLC to bladder often presents in patients with a remote history of breast cancer, exhibiting significant histologic and immunohistochemical overlap with PUC. Based on prior works and the current study, estrogen receptor (particularly SP-1), mammaglobin, and p63 help differentiate MPLC from PUC. Keratin 5/6 may aid in distinguishing a less frequent basal-type PUC because it is typically negative in MPLC. Some PUCs express TRPS1. Caution should be exercised because immunophenotypes of these tumors greatly overlap, and ramifications of misclassification are major.</p>","PeriodicalId":93883,"journal":{"name":"Archives of pathology & laboratory medicine","volume":" ","pages":"1110-1118"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139467491","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Harnessing the Power of Generative Artificial Intelligence in Pathology Education. 在病理学教育中利用生成式人工智能的力量。
Pub Date : 2024-09-30 DOI: 10.5858/arpa.2024-0187-RA
Matthew J Cecchini, Michael J Borowitz, Eric F Glassy, Rama R Gullapalli, Steven N Hart, Lewis A Hassell, Robert J Homer, Ronald Jackups, Jeffrey L McNeal, Scott R Anderson

Context.—: Generative artificial intelligence (AI) technologies are rapidly transforming numerous fields, including pathology, and hold significant potential to revolutionize educational approaches.

Objective.—: To explore the application of generative AI, particularly large language models and multimodal tools, for enhancing pathology education. We describe their potential to create personalized learning experiences, streamline content development, expand access to educational resources, and support both learners and educators throughout the training and practice continuum.

Data sources.—: We draw on insights from existing literature on AI in education and the collective expertise of the coauthors within this rapidly evolving field. Case studies highlight practical applications of large language models, demonstrating both the potential benefits and unique challenges associated with implementing these technologies in pathology education.

Conclusions.—: Generative AI presents a powerful tool kit for enriching pathology education, offering opportunities for greater engagement, accessibility, and personalization. Careful consideration of ethical implications, potential risks, and appropriate mitigation strategies is essential for the responsible and effective integration of these technologies. Future success lies in fostering collaborative development between AI experts and medical educators, prioritizing ongoing human oversight and transparency to ensure that generative AI augments, rather than supplants, the vital role of educators in pathology training and practice.

背景生成式人工智能(AI)技术正在迅速改变包括病理学在内的众多领域,并具有彻底改变教育方法的巨大潜力:探索生成式人工智能的应用,特别是大型语言模型和多模态工具,以加强病理学教育。我们描述了它们在创建个性化学习体验、简化内容开发、扩大教育资源获取途径以及在整个培训和实践过程中为学习者和教育者提供支持的潜力:我们借鉴了有关教育领域人工智能的现有文献中的见解,以及共同作者在这一快速发展的领域中的集体专业知识。案例研究突出了大型语言模型的实际应用,展示了在病理学教育中实施这些技术的潜在益处和独特挑战:生成式人工智能为丰富病理学教育提供了一个强大的工具包,为提高参与度、可及性和个性化提供了机会。认真考虑伦理影响、潜在风险和适当的缓解策略对于负责任地有效整合这些技术至关重要。未来的成功在于促进人工智能专家与医学教育工作者之间的合作开发,优先考虑持续的人工监督和透明度,以确保生成式人工智能增强而非取代教育工作者在病理学培训和实践中的重要作用。
{"title":"Harnessing the Power of Generative Artificial Intelligence in Pathology Education.","authors":"Matthew J Cecchini, Michael J Borowitz, Eric F Glassy, Rama R Gullapalli, Steven N Hart, Lewis A Hassell, Robert J Homer, Ronald Jackups, Jeffrey L McNeal, Scott R Anderson","doi":"10.5858/arpa.2024-0187-RA","DOIUrl":"https://doi.org/10.5858/arpa.2024-0187-RA","url":null,"abstract":"<p><strong>Context.—: </strong>Generative artificial intelligence (AI) technologies are rapidly transforming numerous fields, including pathology, and hold significant potential to revolutionize educational approaches.</p><p><strong>Objective.—: </strong>To explore the application of generative AI, particularly large language models and multimodal tools, for enhancing pathology education. We describe their potential to create personalized learning experiences, streamline content development, expand access to educational resources, and support both learners and educators throughout the training and practice continuum.</p><p><strong>Data sources.—: </strong>We draw on insights from existing literature on AI in education and the collective expertise of the coauthors within this rapidly evolving field. Case studies highlight practical applications of large language models, demonstrating both the potential benefits and unique challenges associated with implementing these technologies in pathology education.</p><p><strong>Conclusions.—: </strong>Generative AI presents a powerful tool kit for enriching pathology education, offering opportunities for greater engagement, accessibility, and personalization. Careful consideration of ethical implications, potential risks, and appropriate mitigation strategies is essential for the responsible and effective integration of these technologies. Future success lies in fostering collaborative development between AI experts and medical educators, prioritizing ongoing human oversight and transparency to ensure that generative AI augments, rather than supplants, the vital role of educators in pathology training and practice.</p>","PeriodicalId":93883,"journal":{"name":"Archives of pathology & laboratory medicine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142334228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Archives of pathology & laboratory medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1